Up-regulation of fatty acid oxidation in the ligament as a contributing factor of ankylosing spondylitis: A comparative proteomic study

Journal of Proteomics

Volumn 113, Issue , 2015, Pages 57-72

  Xu, Wei Dong ^a   Yang, Xin Yu ^b   Li, Da He ^a   Zheng, Kai Di ^b   Qiu, Peng Cheng ^b   Zhang, Wei ^b   Li, Chun Yang ^b   Lei, Kang Fu ^b   Yan, Guo Quan ^c   Jin, Sheng Wei ^d   Wang, Jian Guang ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Ankylosing spondylitis; Fatty acid oxidation; Fibroblast like ligament cells; IPA; Proteomics

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ENOYL COENZYME A HYDRATASE; ENOYL COENZYME A HYDRATASE 1; FATTY ACID; HYDROXYACYL COENZYME A DEHYDROGENASE; INSULIN RECEPTOR SUBSTRATE 1; LONG CHAIN FATTY ACID COENZYME A LIGASE; LONG CHAIN FATTY ACID COENZYME A LIGASE 1; LONG CHAIN FATTY ACID COENZYME A LIGASE 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PROTEOME;

ANKYLOSING SPONDYLITIS; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; FATTY ACID OXIDATION; FIBROBLAST; HUMAN; INTRACELLULAR SPACE; LIGAMENT; LIQUID CHROMATOGRAPHY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; COMPARATIVE STUDY; FEMALE; LIPID METABOLISM; MALE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

FATTY ACIDS; FEMALE; HUMANS; LIGAMENTS; LIPID METABOLISM; MALE; OXIDATION-REDUCTION; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SPONDYLITIS, ANKYLOSING; UP-REGULATION;

EID: 84907992169     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.09.014     Document Type: Article

References (30)

1. Braun J., Sieper J. Ankylosing spondylitis. Lancet 2007, 369:1379-1390.
2. Dougados M., Baeten D. Spondyloarthritis. Lancet 2011, 377:2127-2137.
3. Thomas G.P., Brown M.A. Genetics and genomics of ankylosing spondylitis. Immunol Rev 2010, 233:162-180.
4. Evans D.M., Spencer C.C., Pointon J.J., Su Z., et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011, 43:761-767.
5. Harvey D., Pointon J.J., Evans D.M., Karaderi T., et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 2009, 18:4204-4212.
6. Karaderi T., Harvey D., Farrar C., Appleton L.H., et al. Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 2009, 48:386-389.
7. Kochan G., Krojer T., Harvey D., Fischer R., et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci U S A 2011, 108:7745-7750.
8. Nguyen T.T., Chang S.C., Evnouchidou I., York I.A., et al. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol 2011, 18:604-613.
9. Liu J., Zhu P., Peng J., Li K., et al. Identification of disease-associated proteins by proteomic approach in ankylosing spondylitis. Biochem Biophys Res Commun 2007, 357:531-536.
10. Fischer R., Trudgian D.C., Wright C., Thomas G., et al. Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis. Mol Cell Proteomics 2012, 11(M111):013904.
11. Li T., Huang Z., Zheng B., Liao Z., et al. Serum disease-associated proteins of ankylosing spondylitis: results of a preliminary study by comparative proteomics. Clin Exp Rheumatol 2010, 28:201-207.
12. Wright, C., Sibani, S., Trudgian, D., Fischer, R., et al., Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteomics, 11, M9 00384.
13. Wright C., Edelmann M., diGleria K., Kollnberger S., et al. Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway. Ann Rheum Dis 2009, 68:1626-1632.
14. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 2001, 19:242-247.
15. Slebos R.J., Brock J.W., Winters N.F., Stuart S.R., et al. Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 2008, 7:5286-5294.
16. van der Linden S., Valkenburg H.A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-368.
17. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
18. Kisselbach L., Merges M., Bossie A., Boyd A. CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures. Cytotechnology 2009, 59:31-44.
19. Sack U., Hirth A., Funke B., Wiedemeyer K., et al. A novel model of fibroblast-mediated cartilage destruction. Scand J Immunol 2005, 61:18-28.
20. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
21. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
22. Lories R.J., Derese I., Ceuppens J.L., Luyten F.P. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 2003, 48:2807-2818.
23. Lin Z., Bei J.X., Shen M., Li Q., et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet 2011, 44:73-77.
24. Tominaga N., Nakahara T., Nasu M., Satoh T. Isolation and characterization of epithelial and myogenic cells by "fishing" for the morphologically distinct cell types in rat primary periodontal ligament cultures. Differentiation 2013, 85:91-100.
25. Eaton S., Bartlett K., Pourfarzam M. Mammalian mitochondrial beta-oxidation. Biochem J 1996, 320(Pt 2):345-357.
26. Sari I., Demir T., Kozaci L.D., Akar S., et al. Body composition, insulin, and leptin levels in patients with ankylosing spondylitis. Clin Rheumatol 2007, 26:1427-1432.
27. Ottaviani S., Allanore Y., Tubach F., Forien M., et al. Body mass index influences the response to infliximab in ankylosing spondylitis. Arthritis Res Ther 2012, 14:R115.
28. Boudina S., Bugger H., Sena S., O'Neill B.T., et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 2009, 119:1272-1283.
29. Takeda J., Seino Y., Fukumoto H., Koh G., et al. PvuII polymorphic sites in the human insulin receptor gene INSR. Nucleic Acids Res 1986, 14:6777.
30. Bai X., Chen X., Liu Y., Tian L., et al. Effects of water extract and crude polysaccharides from Liriope spicata var. prolifera on InsR/IRS-1/PI3K pathway and glucose metabolism in mice. J Ethnopharmacol 2009, 125:482-486.